1644545-52-7

1644545-52-7 structure
1644545-52-7 structure

Name AG881
Synonyms N,N-dimethyl-N-(oxiran-2-ylmethyl)octadecan-1-aminium chloride
4-(2-acetyl-5-chlorophenyl)-5-methoxypyridin-2(1H)-one
FF10101
UK2001607
Trichloroethyl 2-(Bromomethyl)-2-hydroxyhehahydrofuro(3,2-b)pyridine-4(2H)-cboxylate
2‐{2‐[2‐(2,2‐difluoroethoxy)ethoxy]ethoxy}‐1,1‐difluoroethane
TLC Plates,Silca Gel 60 F254 Aluminium Plating
PCB138
CALCIUM(C10-C16)ALKYLBENZENESULPHONATE
(5Z,8Z,11Z,14Z)-15-Hydroperoxyicosa-5,8,11,14-tetraenoic acid
Vorasidenib (AG881)
2,2'-(propane-2,2- diylbis(sulfanediyl))bis(ethan-1-ol)
HS-01
4-Cyano-1-(perfluoroethoxy)pyridin-1-ium bis((trifluoromethyl)sulfonyl)amide
6-(6-chloropyridin-2-yl)-N2,N4-bis((R)-1,1,1-trifluoropropan-2-yl)-1,3,5-triazine-2,4-diamine
4-hydrazineylnicotinamide
15-HPETE
E-7386
SRD5A1-IN-1
s-22611
high quality 3-aminophenylacetylene HCL
N-Trifluoromethyltriazolyl-4-cboxamide
2-(1-ethoxyvinyl)-4,4,5,5-tetraethyl-1,3,2-dioxaborolane
N-Difluoromethyltriazolyl-4-cboxamide
Sodium 2,3,3,3-Tetrafluoro-2-(1,1,2,2,2-Pentafluoroethoxy)propanoate
1,3,5-Triazine-2,4-diamine, 6-(6-chloro-2-pyridinyl)-N2,N4-bis[(1R)-2,2,2-trifluoro-1-methylethyl]
FM381 FM-381
15-HYDROPEROXYEICOSATETRAENOICACID
FF-10101
Amino Cboxyl Magnetic Beads
Sodium 2-azido-2,2-difluoroacetate
Vorasidenib
IMB-XH1
inhibit,AG 881,Vorasidenib,AG881,Inhibitor,Isocitrate Dehydrogenase (IDH)
S-N-NITROSO-2-METHYLPIPERIDINE
(E)-Ethyl Docos-2-Enoate
2-chloro-N1,N4-bis(4-cyanophenyl)terhthalamide
AG-881
AG 881; AG-881
(S)-1-amino-1-(5-bromo-2-fluorophenyl)ethan-1-ol
4-N-(2,4-dimethoxyphenyl)-6-N-(4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-4,6-diamine, N4-(2,4-dimethoxyphenyl)-N6-(4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-4,6-diamine
2-[1-(2-Hydroxy-ethylsulfanyl)-1-methyl-ethylsulfanyl]-ethanol
benzyl ester of L-cnitine
(+)-Quassin
2-[3-(2H-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazin-1-yl]-N-(4-methoxyphenyl)-N-propan-2-ylacetamide
1-Difluoroethyltriazolyl-4-methylamine hydrochloride
AG081
(1-(2,2,3,3-Tetrafluoropropyl)-1H-1,2,3-triazol-4-yl)methanaminium chloride
PF06291874
FLEABUSTERSRXPOWDER
E7386
3-bromo-5-bromoacetyl salicylamide
AKR1C3-IN-9
(5Z,8Z,11Z,14Z)-15-Hydroperoxy-5,8,11,14-icosatetraenoic acid
(R)-1-(3-(3-amino-6-(2-fluoro-5-isopropoxyphenyl)pyrazine-2-cboxamido)pyridin-4-yl)piperidine-3-cboxylic acid
PVM/MA
Description Vorasidenib is a pan isocitrate dehydrogenase (IDH) inhibitor.
Related Catalog
Target

IDH[1]

In Vitro Vorasidenib has recently entered phase 1 clinical trials in hematologic (NCT02492737) and solid malignancies (NCT02481154) in patients with either an IDH1 or an IDH2 mutation. Preclinical studies have suggested that Vorasidenib fully penetrates the blood-brain barrier and may be a more effective option for patients with IDH1/2 mutated glioma[1].
References

[1]. Fujii T, et al. Targeting isocitrate dehydrogenase (IDH) in cancer. Discov Med. 2016 May;21(117):373-80.

Molecular Formula C14H13ClF6N6
Molecular Weight 414.74
Storage condition -20℃
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.